Shopping Cart 0
Cart Subtotal
USD 0

Albert Einstein College of Medicine - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
USD 750

Details

Summary

Albert Einstein College of Medicine (AECM) a subsidiary of Montefiore Medical Center is a healthcare service provider that offers educational services. The institute operates as a research institute for medical education, basic research and clinical investigation. It offers education programs such as graduate medical education, graduate program, masters in bioethics, master of public health, medical program, masters in clinical research and MSTP program, among others. AECM provides its courses through departments such as anatomy structural biology, anesthesiology, biochemistry, cardiovascular and thoracic surgery, cell biology, dentistry, development and molecular biology. The institute also operates through departments including emergency medicine, genetics, medicine, microbiology and immunology, molecular pharmacology, pediatrics, physiology and biophysics and radiation oncology. AECM is headquartered in Bronx, New York, the US.

Albert Einstein College of Medicine-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Albert Einstein College of Medicine, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Albert Einstein College of Medicine, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Albert Einstein College of Medicine, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Albert Einstein College of Medicine, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Albert Einstein College of Medicine, Medical Devices Deals, 2012 to YTD 2018 10

Albert Einstein College of Medicine, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Albert Einstein College of Medicine, Pharmaceuticals & Healthcare, Deal Details 12

Partnerships 12

MetaStat Enters Into Licensing Agreement With Albert Einstein College of Medicine For Metastatic Cell Technology Patents 12

Immune-Onc Therapeutics Enters into Research Agreement with Albert Einstein College of Medicine 13

Jiangsu Hengrui Medicine to Form Partnership With Albert Einstein College of Medicine 14

Actinium Pharma Enters into Co-Development Agreement with Albert Einstein College of Medicine 15

Licensing Agreements 16

Immune-Onc Therapeutics Enters into Licensing Agreement with Albert Einstein College of Medicine and Memorial Sloan Kettering Cancer Center 16

Cue Biopharma Amends License Agreement with Albert Einstein 17

Nexus BioPharma Enters into Licensing Agreement with Albert Einstein College of Medicine 18

MetaStat Enters Into Licensing Agreements For Alternative Splicing Program 19

Albert Einstein College of Medicine-Key Competitors 21

Albert Einstein College of Medicine-Key Employees 22

Albert Einstein College of Medicine-Locations And Subsidiaries 23

Head Office 23

Other Locations & Subsidiaries 23

Recent Developments 24

Government and Public Interest 24

Jun 03, 2018: TAILORx Trial Finds Most Women with Early Breast Cancer Do Not Benefit from Chemotherapy 24

May 14, 2018: Einstein and Montefiore Awarded USD 25 Million from the NIH to Continue Its Institute for Clinical and Translational Research 26

Nov 29, 2017: Einstein Receives USD 174 Million in Fiscal Year 2017 28

Nov 27, 2017: Increased Oral Pathogens and Decreased Bacterial Diversity Predict Precancerous Lesions of Stomach Cancer 29

Nov 14, 2017: Einstein researchers receive USD 6 million grant to untangle the genetic protections against Alzheimer's disease 30

Nov 06, 2017: NIH Funds Research to Fight Alzheimer's Disease with Anti-Inflammatory Diet 31

Oct 19, 2017: Study Shows How Nerves Drive Prostate Cancer 32

Oct 16, 2017: Einstein Researchers Share USD 9 Million Grant to Find Anti-Aging Therapies 33

Oct 16, 2017: Scripps Florida Scientists Share USD 9 Million Grant to Develop Therapies that Target the Aging Process 34

Oct 09, 2017: Novel Treatment Causes Cancer to Self-Destruct Without Affecting Healthy Cells 35

Oct 06, 2017: FDA awards 15 grants for clinical trials to stimulate product development for rare diseases 37

Aug 22, 2017: Einstein Researchers Awarded USD 3 Million for Longevity and Aging Studies 39

Aug 08, 2017: First Long-Term Study on Medical Marijuana's Impact on Opioid Use for Pain 40

Jul 12, 2017: Montefiore And Einstein Awarded USD 3.4 Million NIH Grant To Integrate Opioid And Tobacco Addiction Treatment 41

Jun 09, 2017: NIH Funds NYC Center for AIDS Research 42

Jan 20, 2017: South African Study Provides Compelling New Evidence on Role of Person-to Person Transmission in Drug-Resistant TB Epidemics 43

Other Significant Developments 44

Aug 09, 2018: Ebola virus experts discover powerful, new approach for future therapeutics 44

May 30, 2018: Montefiore And Einstein Break Barriers With First Picture-Based Dementia Screening Tool 46

Appendix 47

Methodology 47

About GlobalData 47

Contact Us 47

Disclaimer 47


List Of Figure

List of Figures

Albert Einstein College of Medicine, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Albert Einstein College of Medicine, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Albert Einstein College of Medicine, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Albert Einstein College of Medicine, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Albert Einstein College of Medicine, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Albert Einstein College of Medicine, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

Albert Einstein College of Medicine, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Albert Einstein College of Medicine, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Albert Einstein College of Medicine, Medical Devices Deals, 2012 to YTD 2018 10


List Of Table

List of Tables

Albert Einstein College of Medicine, Pharmaceuticals & Healthcare, Key Facts 2

Albert Einstein College of Medicine, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Albert Einstein College of Medicine, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Albert Einstein College of Medicine, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Albert Einstein College of Medicine, Deals By Therapy Area, 2012 to YTD 2018 9

Albert Einstein College of Medicine, Medical Devices Deals, 2012 to YTD 2018 10

Albert Einstein College of Medicine, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

MetaStat Enters Into Licensing Agreement With Albert Einstein College of Medicine For Metastatic Cell Technology Patents 12

Immune-Onc Therapeutics Enters into Research Agreement with Albert Einstein College of Medicine 13

Jiangsu Hengrui Medicine to Form Partnership With Albert Einstein College of Medicine 14

Actinium Pharma Enters into Co-Development Agreement with Albert Einstein College of Medicine 15

Immune-Onc Therapeutics Enters into Licensing Agreement with Albert Einstein College of Medicine and Memorial Sloan Kettering Cancer Center 16

Cue Biopharma Amends License Agreement with Albert Einstein 17

Nexus BioPharma Enters into Licensing Agreement with Albert Einstein College of Medicine 18

MetaStat Enters Into Licensing Agreements For Alternative Splicing Program 19

Albert Einstein College of Medicine, Key Competitors 21

Albert Einstein College of Medicine, Key Employees 22

Albert Einstein College of Medicine, Subsidiaries 23

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Albert Einstein College of Medicine, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Company Profile

Company Profile Title

Summary

Albert Einstein College of Medicine (AECM) a subsidiary of Montefiore Medical Center is a healthcare service provider that offers educational services. The institute operates as a research institute for medical education, basic research and clinical investigation. It offers education programs such as graduate medical education, graduate program, masters in bioethics, master of public health, medical program, masters in clinical research and MSTP program, among others. AECM provides its courses through departments such as anatomy structural biology, anesthesiology, biochemistry, cardiovascular and thoracic surgery, cell biology, dentistry, development and molecular biology. The institute also operates through departments including emergency medicine, genetics, medicine, microbiology and immunology, molecular pharmacology, pediatrics, physiology and biophysics and radiation oncology. AECM is headquartered in Bronx, New York, the US.

Albert Einstein College of Medicine-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Albert Einstein College of Medicine, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Albert Einstein College of Medicine, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Albert Einstein College of Medicine, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Albert Einstein College of Medicine, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Albert Einstein College of Medicine, Medical Devices Deals, 2012 to YTD 2018 10

Albert Einstein College of Medicine, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Albert Einstein College of Medicine, Pharmaceuticals & Healthcare, Deal Details 12

Partnerships 12

MetaStat Enters Into Licensing Agreement With Albert Einstein College of Medicine For Metastatic Cell Technology Patents 12

Immune-Onc Therapeutics Enters into Research Agreement with Albert Einstein College of Medicine 13

Jiangsu Hengrui Medicine to Form Partnership With Albert Einstein College of Medicine 14

Actinium Pharma Enters into Co-Development Agreement with Albert Einstein College of Medicine 15

Licensing Agreements 16

Immune-Onc Therapeutics Enters into Licensing Agreement with Albert Einstein College of Medicine and Memorial Sloan Kettering Cancer Center 16

Cue Biopharma Amends License Agreement with Albert Einstein 17

Nexus BioPharma Enters into Licensing Agreement with Albert Einstein College of Medicine 18

MetaStat Enters Into Licensing Agreements For Alternative Splicing Program 19

Albert Einstein College of Medicine-Key Competitors 21

Albert Einstein College of Medicine-Key Employees 22

Albert Einstein College of Medicine-Locations And Subsidiaries 23

Head Office 23

Other Locations & Subsidiaries 23

Recent Developments 24

Government and Public Interest 24

Jun 03, 2018: TAILORx Trial Finds Most Women with Early Breast Cancer Do Not Benefit from Chemotherapy 24

May 14, 2018: Einstein and Montefiore Awarded USD 25 Million from the NIH to Continue Its Institute for Clinical and Translational Research 26

Nov 29, 2017: Einstein Receives USD 174 Million in Fiscal Year 2017 28

Nov 27, 2017: Increased Oral Pathogens and Decreased Bacterial Diversity Predict Precancerous Lesions of Stomach Cancer 29

Nov 14, 2017: Einstein researchers receive USD 6 million grant to untangle the genetic protections against Alzheimer's disease 30

Nov 06, 2017: NIH Funds Research to Fight Alzheimer's Disease with Anti-Inflammatory Diet 31

Oct 19, 2017: Study Shows How Nerves Drive Prostate Cancer 32

Oct 16, 2017: Einstein Researchers Share USD 9 Million Grant to Find Anti-Aging Therapies 33

Oct 16, 2017: Scripps Florida Scientists Share USD 9 Million Grant to Develop Therapies that Target the Aging Process 34

Oct 09, 2017: Novel Treatment Causes Cancer to Self-Destruct Without Affecting Healthy Cells 35

Oct 06, 2017: FDA awards 15 grants for clinical trials to stimulate product development for rare diseases 37

Aug 22, 2017: Einstein Researchers Awarded USD 3 Million for Longevity and Aging Studies 39

Aug 08, 2017: First Long-Term Study on Medical Marijuana's Impact on Opioid Use for Pain 40

Jul 12, 2017: Montefiore And Einstein Awarded USD 3.4 Million NIH Grant To Integrate Opioid And Tobacco Addiction Treatment 41

Jun 09, 2017: NIH Funds NYC Center for AIDS Research 42

Jan 20, 2017: South African Study Provides Compelling New Evidence on Role of Person-to Person Transmission in Drug-Resistant TB Epidemics 43

Other Significant Developments 44

Aug 09, 2018: Ebola virus experts discover powerful, new approach for future therapeutics 44

May 30, 2018: Montefiore And Einstein Break Barriers With First Picture-Based Dementia Screening Tool 46

Appendix 47

Methodology 47

About GlobalData 47

Contact Us 47

Disclaimer 47


List Of Figure

List of Figures

Albert Einstein College of Medicine, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Albert Einstein College of Medicine, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Albert Einstein College of Medicine, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Albert Einstein College of Medicine, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Albert Einstein College of Medicine, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Albert Einstein College of Medicine, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

Albert Einstein College of Medicine, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Albert Einstein College of Medicine, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Albert Einstein College of Medicine, Medical Devices Deals, 2012 to YTD 2018 10


List Of Table

List of Tables

Albert Einstein College of Medicine, Pharmaceuticals & Healthcare, Key Facts 2

Albert Einstein College of Medicine, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Albert Einstein College of Medicine, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Albert Einstein College of Medicine, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Albert Einstein College of Medicine, Deals By Therapy Area, 2012 to YTD 2018 9

Albert Einstein College of Medicine, Medical Devices Deals, 2012 to YTD 2018 10

Albert Einstein College of Medicine, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

MetaStat Enters Into Licensing Agreement With Albert Einstein College of Medicine For Metastatic Cell Technology Patents 12

Immune-Onc Therapeutics Enters into Research Agreement with Albert Einstein College of Medicine 13

Jiangsu Hengrui Medicine to Form Partnership With Albert Einstein College of Medicine 14

Actinium Pharma Enters into Co-Development Agreement with Albert Einstein College of Medicine 15

Immune-Onc Therapeutics Enters into Licensing Agreement with Albert Einstein College of Medicine and Memorial Sloan Kettering Cancer Center 16

Cue Biopharma Amends License Agreement with Albert Einstein 17

Nexus BioPharma Enters into Licensing Agreement with Albert Einstein College of Medicine 18

MetaStat Enters Into Licensing Agreements For Alternative Splicing Program 19

Albert Einstein College of Medicine, Key Competitors 21

Albert Einstein College of Medicine, Key Employees 22

Albert Einstein College of Medicine, Subsidiaries 23

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Albert Einstein College of Medicine, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.